2-methoxyestradiol - CAS 362-07-2
Catalog number:
362-07-2
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
HIF/HIF Prolyl-Hydroxylase
Description:
2-methoxyestradiol, also known as 2-ME, is an orally bioavailable estradiol metabolite with potential antineoplastic activity. 2-Methoxyestradiol inhibits angiogenesis by reducing endothelial cell proliferation and inducing endothelial cell apoptosis. This agent also inhibits tumor cell growth by binding to tubulin, resulting in antimitotic activity, and by inducing caspase activation, resulting in cell cycle arrest in the G2 phase, DNA fragmentation, and apoptosis.
Publictions citing BOC Sciences Products
  • >> More
Purity:
0.98
Appearance:
white solid powder
Synonyms:
2-ME; 2-Methoxy Estradiol. US brand name: Panzem. Abbreviation: 2ME2. Chemical structure name: (17beta)-2-Methoxyestra-1,3,5(10)-triene-3,17-diol.
MSDS:
Inquire
Current Developer:
EntreMed, Inc.
1.Recent Advances in chemistry and pharmacology of 2-methoxyestradiol: An anticancer investigational drug.
Kumar BS1, Raghuvanshi DS1, Hasanain M2, Alam S1, Sarkar J2, Mitra K2, Khan F1, Negi AS3. Steroids. 2016 Mar 26. pii: S0039-128X(16)30001-0. doi: 10.1016/j.steroids.2016.03.017. [Epub ahead of print]
2-Methoxyestradiol (2ME2), an estrogen hormone metabolite is a potential cancer chemotherapeutic agent. Presently, it is an investigational drug under various phases of clinical trials alone or in combination therapy. Its anticancer activity has been attributed to its antitubulin, antiangiogenic, pro-apoptotic and ROS induction properties. This anticancer drug candidate has been explored extensively in last twenty years for its detailed chemistry and pharmacology. Present review is an update of its chemistry and biological activity. It also extends an assessment of potential of 2ME2 and its analogues as possible anticancer drug in future.
2.Nitro-oxidative Stress Is Involved in Anticancer Activity of 17β-Estradiol Derivative in Neuroblastoma Cells.
Gorska M1, Kuban-Jankowska A2, Milczarek R3, Wozniak M2. Anticancer Res. 2016 Apr;36(4):1693-8.
Neuroblastoma is one of the most common childhood malignancies and the primary cause of death from pediatric cancer. Derivatives of 17β-estradiol, 2-methoxyestradiol, as well as selective estrogen receptor modulators, such as fulvestrant, are novel potentially active anticancer agents. In particular, 2-methoxyestradiol is effective in treatment of numerous malignancies, including breast and prostate cancer, Ewing sarcoma, and osteosarcoma. Herein, we treated neuroblastoma SH-SY5Y cells with physiologically and pharmacologically relevant concentrations of 2-methoxyestradiol. We used flow cytometry in order to determine cell viability, cell death, level of nitric oxide and mitochondrial membrane potential. We demonstrated that at pharmacologically relevant concentrations, 2-methoxyestradiol results in induction of apoptosis of neuroblastoma SH-SY5Y cells via nitric oxide generation and reduction of mitochondrial membrane potential. Based on the obtained data, we propose that 2-methoxyestradiol may be a natural modulator of cancer cell death and survival through nitro-oxidative stress-dependent mechanisms.
3.[Effect of 2-methoxyestradiol combined with quercetin on prostate cancer in vitro].
Song LM1, Wang GD, Wang HP, Xing NZ. Zhonghua Yi Xue Za Zhi. 2016 Jan 12;96(2):95-9. doi: 10.3760/cma.j.issn.0376-2491.2016.02.004.
OBJECTIVE: To detect the effects of quercetin (Que) combined with 2-methoxyestradiol (2-ME) on the proliferation of androgen-dependent LNCaP human prostate cancer cells line and androgen-independent PC-3 human prostate cancer cells line, and to evaluate the antitumor effects of different combos of the two drugs.
4.Oxidative pathways in response to polyunsaturated aldehydes in the marine diatom Skeletonema marinoi (Bacillariophyceae).
Gallina AA1, Palumbo A1, Casotti R1. J Phycol. 2016 Apr 8. doi: 10.1111/jpy.12421. [Epub ahead of print]
Polyunsaturated aldehydes (PUA) have recently been shown to induce reactive oxygen species (ROS) and possibly reactive nitrogen species (RNS, e.g. peroxynitrite) in the diatom Skeletonema marinoi (S. marinoi), which produces high amounts of PUA. We now are attempting to acquire better understanding of which reactive molecular species are involved in the oxidative response of S. marinoi to PUA. We used flow cytometry, the dye Dihydrorhodamine 123 (DHR) as the main indicator of ROS (but which is also known to partially detect RNS), and different scavengers and inhibitors of both NO synthesis and superoxide dismutase activity (SOD). Both the scavengers Tempol (for ROS) and Uric Acid (UA, for peroxynitrite) induced a lower DHR-derived green fluorescence in S. marinoi cells exposed to the PUA, suggesting that both reactive species were produced. When PUA-exposed S. marinoi cells were treated with the NO scavenger 2-4-carboxyphenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (cPTIO), an opposite response was observed, with an increase in DHR-derived green fluorescence.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related HIF/HIF Prolyl-Hydroxylase Products


CAS 327-97-9 Chlorogenic Acid

Chlorogenic Acid
(CAS: 327-97-9)

Chlorogenic acid is a hydroxycinnamic acid and a member of a family of naturally occurring organic compounds.

CAS 1154028-82-6 Molidustat

Molidustat
(CAS: 1154028-82-6)

Molidustat, also known as BAY 85-3934, is a novel inhibitor of hypoxia-inducible factor (HIF) prolyl hydroxylase (PH) which stimulates erythropoietin (EPO) prod...

FG-2216
(CAS: 223387-75-5)

FG-2216, also known as YM311, is orally bioavailable HIF-prolyl hydroxylase inhibitor. FG-2216 induced significant and reversible Epo induction in vivo.

CAS 89464-63-1 DMOG

DMOG
(CAS: 89464-63-1)

DMOG is an antagonist of α-ketoglutarate cofactor and inhibitor for HIF prolyl hydroxylase.

CAS 685898-44-6 PX-478

PX-478
(CAS: 685898-44-6)

PX-478 is HIF-1alpha inhibitor, is also an orally active small molecule with potential antineoplastic activity. Although its mechanism of action has yet to be ...

CAS 931398-72-0 IOX2

IOX2
(CAS: 931398-72-0)

CAS 1187990-87-9 MK-8617

MK-8617
(CAS: 1187990-87-9)

MK-8617 is a potent and selective pan-inhibitor of Hypoxia-inducible factor prolyl hydroxylase 1−3 (HIF PHD1−3) (PHD1: IC50 = 1.0 nM; PHD2: IC50 =1.0nM; PHD3: I...

KC7F2
(CAS: 927822-86-4)

KC7F2 is a selective HIF-1α transcription inhibitor with IC50 of 20 μM in a cell-based assay.

THS-044
(CAS: 62054-67-5)

THS-044 binding stabilizes the HIF2α PAS-B folded state, for regulating HIF2 activity in endogenous and clinical settings.

JNJ-42041935
(CAS: 1193383-09-3)

JNJ-42041935 is a potent (pK(I) = 7.3-7.9), 2-oxoglutarate competitive, reversible, and selective inhibitor of PHD enzymes. JNJ-42041935 is a new pharmacologica...

CAS 808118-40-3 Roxadustat (FG-4592)

Roxadustat (FG-4592)
(CAS: 808118-40-3)

Roxadustat (FG-4592) is an HIF α prolyl hydroxylase inhibitor, stabilizes HIF-2 and induces EPO production.

CAS 362-07-2 2-methoxyestradiol

2-methoxyestradiol
(CAS: 362-07-2)

2-methoxyestradiol, also known as 2-ME, is an orally bioavailable estradiol metabolite with potential antineoplastic activity. 2-Methoxyestradiol inhibits angio...

CAS 1357171-62-0 ML228

ML228
(CAS: 1357171-62-0)

HIF pathway activator (EC50 values are 1.23 and 1.4 μM for HRE gene reporter assay and HIF-1α nuclear translocation assay respectively); acts via chelation of i...

CAS 64224-21-1 Oltipraz

Oltipraz
(CAS: 64224-21-1)

Oltipraz, a promising cancer chemopreventive agent, is a bifunctional inducer, modulating both phase I and II drug-metabolizing enzymes to enhance carcinogen de...

Daprodustat
(CAS: 960539-70-2)

Daprodustat, also known as GSK1278863, is a novel HIF-prolyl hydroxylase inhibitor. Hypoxia inducible factor (HIF) stabilization by HIF-prolyl hydroxylase (PHD)...

PT-2385
(CAS: 1672665-49-4)

PT-2385 is a small molecule inhibitor with oral activity that inhibits hypoxia inducible factor (HIF)-2alpha heterodimerization and its subsequent binding to DN...

CAS 1227158-85-1 BAY 87-2243

BAY 87-2243
(CAS: 1227158-85-1)

BAY 87-2243 inhibits HIF-1 reporter gene activity and CA9 protein expression with IC50 of 0.7 nM and 2 nM, respectively.

DASA-58
(CAS: 1203494-49-8)

DASA-58 is a specific and potent Pyruvate kinase M2 (PKM2) activator.

Chemical Structure

CAS 362-07-2 2-methoxyestradiol

Quick Inquiry

Verification code

Featured Items